RNU6-943P

Across TCGA pan-cancer cohorts, RNU6-943P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-943P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-943P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-943P expression acts as an unfavorable survival marker.

STAD, BRCA, and MESO are the cancer types where RNU6-943P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.447	0.741	.002	54	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
KIRC	DFS	Tertile	IV	0.092	0.631	.013	18	view →
SKCM	DFS	Tertile	II,III,IV	0.136	0.708	.018	9	view →
LIHC	OS	Tertile	All	0.226	0.673	.037	9	view →
LUSC	OS	Tertile	III,IV	0.167	0.420	.036	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-943P–STAD (DFS)

Open the STAD breakdown →